7 Results

People

  1. Zabor
    Zabor
  2. Morrow
    Morrow
  3. Stempel
    Stempel
  4. Barrio
    Barrio
  5. Gemignani
    Gemignani
  6. Mamtani
    Mamtani
  7. Cassidy
    Cassidy
  8. Christian
    Christian
  9. Edelweiss
    Edelweiss
  10. Flanagan
    Flanagan

Groups

  1. Surgery (7)
  2. Breast Cancer Disease Management Team (5)
  3. Josie Robertson Surgery Center (1)
  4. Sloan Kettering Institute Postdocs (1)
Refine Results
  1. "major clinical study"
  2. "Journal article"
  3. "Monica Morrow"
  4. "Emily Zabor"
  5. "Annals of Surgical Oncology"
Formats
  1. Journal Article (7)
Groups
  1. Surgery (7)
  2. Breast Cancer Disease Management Team (5)
  3. Josie Robertson Surgery Center (1)
  4. Sloan Kettering Institute Postdocs (1)
People
  1. Emily Zabor (7)
  2. Monica Morrow (7)
  3. Michelle Stempel (6)
  4. Andrea Barrio (3)
  5. Anita Mamtani (3)
  6. Mary Gemignani (3)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2018 (1)
  4. 2017 (2)
Publications
  1. Annals of Surgical Oncology (7)
Publishers
  1. Springer (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Contralateral prophylactic mastectomy use after neoadjuvant chemotherapy
    Journal Article

    Christian, N.; Zabor, E. C.; Cassidy, M.; Flynn, J.; Morrow, M.; Gemignani, M. L.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Was reexcision less frequent for patients with lobular breast cancer after publication of the SSO-ASTRO margin guidelines?
    Journal Article

    Mamtani, A.; Zabor, E. C.; Rosenberger, L. H.; Stempel, M.; Gemignani, M. L.; Morrow, M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction
    Journal Article

    Flanagan, M. R.; Zabor, E. C.; Romanoff, A.; Fuzesi, S.; Stempel, M.; Mehrara, B. J.; Morrow, M.; Pusic, A. L.; Gemignani, M. L.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Lobular histology does not predict the need for axillary dissection among ACOSOG Z0011-eligible breast cancers
    Journal Article

    Mamtani, A.; Zabor, E. C.; Stempel, M.; Morrow, M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?
    Journal Article

    Moo, T. A.; Edelweiss, M.; Hajiyeva, S.; Stempel, M.; Raiss, M.; Zabor, E. C.; Barrio, A.; Morrow, M.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor biology predicts pathologic complete response to neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer
    Journal Article

    Gentile, L. F.; Plitas, G.; Zabor, E. C.; Stempel, M.; Morrow, M.; Barrio, A. V.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • The optimal treatment plan to avoid axillary lymph node dissection in early-stage breast cancer patients differs by surgical strategy and tumor subtype
    Journal Article

    Pilewskie, M.; Zabor, E. C.; Mamtani, A.; Barrio, A. V.; Stempel, M.; Morrow, M.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save